Long COVID Atlas
Text Theme
Note

A raised risk is not a certainty. This page is about proportion, not alarm; new cardiac symptoms still deserve prompt attention.

Outcome · Cardiovascular

Cardiovascular risk after COVID

Large studies show that COVID raises the risk of new heart and vessel problems in the year that follows, even after mild infection. The finding is real and worth taking seriously. It is also widely misread. Read in absolute terms, the risk is raised, not a sentence, and that distinction matters for how you live with it.

Short version: in the year after COVID the risk of a new cardiovascular event is higher than in people who were not infected, but most people have no event. The point is to manage risk sensibly, not to panic.

What the data show

In a study of more than 150,000 people followed for a year after COVID, the risk of new cardiovascular problems, from irregular rhythms to heart failure to clots, was raised across the board compared with people who were not infected, with the risk of major events about 1.6 times higher and the effect present even after mild infection.1

A raised risk, kept in proportion no COVIDbaseline after COVIDabout 1.6x about 45 extra cardiovascular events per 1,000 people in the year after COVID; roughly 955 in 1,000 have none
In a study of more than 150,000 people, the risk of a new cardiovascular problem in the year after COVID was about 1.6 times higher than in people who were not infected. That sounds alarming until you read it in absolute terms: roughly 45 extra events per 1,000 people over a year, which means the great majority have no event at all. The risk is raised, not a certainty, and that distinction is the whole point.

Kept in proportion

The same study, read in absolute terms, found roughly 45 extra cardiovascular events per 1,000 people over the year. That means about 955 in 1,000 had none. The relative increase is real and worth respecting; it is also not a sentence. And because this is observational data, some of the gap may reflect differences between people who caught COVID and those who did not, not COVID alone.1

large cohort observational

What drives it

The mechanisms are the ones this site covers: endothelial dysfunction in the vessel lining, abnormal clotting, and the strain that dysautonomia puts on the heart and vessels. The raised risk is the downstream sum of those.

What to do

The useful response is neither panic nor dismissal. Manage the risk factors you can, and treat new or worsening chest pain, breathlessness, fainting, or palpitations as a reason to be seen rather than to wait. Where an autonomic or POTS pattern is driving palpitations, that substrate is treatable.

What we don't know

Honest about the edges of the evidence. These are open questions, not settled answers.

  • How much of the raised risk is caused by COVID itself versus differences between groups.
  • How long the elevated risk lasts, and whether it fades.
  • Whether vaccination or antiviral treatment lowers the later cardiovascular risk.
  • Which people are most vulnerable, so attention can be focused.
  • Whether treating the underlying mechanisms reduces events.

References

Every reference is free to read in full.

  1. Xie Y, et al. Long-term cardiovascular outcomes of COVID-19. Nature Medicine, 2022.

Associated topics